We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Atherogenic Role Seen for C-Reactive Protein

By Biotechdaily staff writers
Posted on 20 Sep 2002
Investigators have found that C-reactive protein (CRP) binds to oxidized low-density lipoprotein (LDL) and that this interaction may lead to the chronic inflammation and buildup of fatty deposits that characterize atherosclerotic plaques. More...
This finding was reported in the September 9, 2002, online edition of the Proceedings of the National Academy of Sciences.

The study showed that CRP is not merely a marker of future cardiovascular events, but that it actually binds to oxidized LDL and to dying cells. Furthermore, the researchers found that binding to CRP was through phosphocholine, which is exposed on the surface of LDL particles that have been oxidized.

CRP plays an important role in the immune response by removing pathogens, and recently CRP has been reported to be a useful marker for predicting future atherosclerotic cardiovascular events, but the basis for this correlation remains unclear. It may be that when the circulatory system is overloaded with oxidized LDL, binding to CRP causes accumulation of fatty material in macrophages. These macrophages become the "foam cells” that are found in atherosclerotic plaques.

The report's senior author, Dr. Joseph Witztum, professor of medicine at the University of California, San Diego (USA; www.ucsd.edu), pointed out that cholesterol is still a key player in coronary heart disease. He said that CRP may be working in its "correct role” as part of the immune response to the toxic oxidized LDL and may help promote its clearance.

"If you have low levels of LDL, and thus, low levels of oxidized LDL, then CRP may be of benefit,” Dr. Witztum said. "However, when there is an overwhelming accumulation of LDL, and thus oxidized LDL, in its attempt to help clear the toxic particle, the CRP may actually make things worse. It may cause more oxidized LDL to be taken up into macrophage scavenger cells, which in turn cause cholesterol accumulation.”




Related Links:
University of California, San Diego

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.